Revolution Medicines Inc (RVMD)
38.85
-0.20
(-0.51%)
USD |
NASDAQ |
May 07, 16:00
38.87
+0.02
(+0.05%)
After-Hours: 20:00
Revolution Medicines Revenue (Quarterly): 0.742M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.742M |
| September 30, 2023 | |
| June 30, 2023 | 3.824M |
| March 31, 2023 | 7.014M |
| December 31, 2022 | 15.33M |
| September 30, 2022 | 3.356M |
| June 30, 2022 | 9.116M |
| March 31, 2022 | 7.578M |
| December 31, 2021 | 9.46M |
| September 30, 2021 | 1.101M |
| June 30, 2021 | 8.698M |
| Date | Value |
|---|---|
| March 31, 2021 | 10.13M |
| December 31, 2020 | 8.751M |
| September 30, 2020 | 12.66M |
| June 30, 2020 | 10.02M |
| March 31, 2020 | 11.55M |
| December 31, 2019 | 12.09M |
| September 30, 2019 | 12.51M |
| June 30, 2019 | 12.28M |
| March 31, 2019 | 13.17M |
| December 31, 2018 | 10.35M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.742M
Minimum
Dec 2023
15.33M
Maximum
Dec 2022
8.678M
Average
9.288M
Median
Revenue (Quarterly) Benchmarks
| Cutera Inc | 49.54M |
| BioSig Technologies Inc | 0.012M |
| TRACON Pharmaceuticals Inc | 3.045M |
| Zentalis Pharmaceuticals Inc | -- |
| Day One Biopharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -161.54M |
| Total Expenses (Quarterly) | 180.72M |
| EPS Diluted (Quarterly) | -1.21 |
| Enterprise Value | 4.545B |
| Profit Margin (Quarterly) | -21.77K% |
| Earnings Yield | -9.88% |
| Normalized Earnings Yield | -9.884 |